155.11MUSD
2.41
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US5034596040
CUSIP
503459505
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
47.85
PEG Ratio
-0.53
Book Value
-0.61
Dividend Share
0
Dividend Yield
0.00%
Earnings Share
0.13
Wall Street Target Price
6.23
EPS Estimate Current Year
0.04
EPS Estimate Next Year
0.23
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0.04
Most Recent Quarter
-
Revenue TTM
46,492,000
Gross Profit TTM
63,081,000
EBITDA
-772,000
Profit Margin
8.54%
Return On Assets TTM
-1.52%
Return On Equity TTM
0.00%
Revenue Per Share TTM
1.749
Qtly Revenue Growth YOY
-34.30%
Diluted Eps TTM
0.13
Qtly Earnings Growth YOY
-27.30%
Trailing PE
47.85
Forward PE
0
Price Sales TTM
3.3362
Price Book MRQ
0
Enterprise Value Revenue
2
Enterprise Value EBITDA
6
32.69
9.24%550.41
2.33%111.73
1.52%466.23
1.46%80.40
0.55%69.67
0.50%152.82
0.06%90.00
0.00%182.50
0.00%3.18
0.00%